Financhill
Back

Immatics NV 10K Form

Sell
31

IMTX
Immatics NV

Last Price:
$11.89
Seasonality Move:
-8.51%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IMTX News And Ratings

See the #1 stock for the next 7 days that we like better than IMTX

IMTX Financial Statistics

Sales & Book Value

Annual Sales: $168.6M
Cash Flow: $-56.2M
Price / Cash Flow: 0
Annual Sales: $4.03
Price / Book: 2.57

Profitability

EPS (TTM): -1.09380
Net Income (TTM): $-133M
Gross Margin: $0
Return on Equity: -25.21%
Return on Assets: -19.94%

Immatics NV Earnings Forecast

Key Immatics NV Financial Ratios

  • The Gross Profit Margin over the past 7 years for IMTX is 0.00%.
  • The Selling, General & Administrative Expenses for IMTX have been equal to 29.81% of Gross Profit Margin.
  • The Research & Development expenses have been 90.72% of Revenue.
  • The Interest Expense is 5.82% of Operating Income.
  • The Net Earning history of IMTX is 9.77% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 4 years.

Immatics NV Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: IMTX
Website: immatics.com

Debt

Debt-to-Equity Ratio: 0.04
Current Ratio: 7.36
Quick Ratio: 6.97

Price-to-Earnings

Trailing P/E Ratio: 67.1
Forward P/E Ratio: 0

IMTX Technical Analysis vs Fundamental Analysis

Sell
31
Immatics NV (IMTX) is a Sell

Is Immatics NV a Buy or a Sell?

  • Immatics NV stock is rated a Sell
    The current Immatics NV [IMTX] share price is $10.34. The Score for IMTX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.